B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Escitalopram

a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

995 PubMed studies analyzed · 572 RCTs · Evidence Score: 73

Research Domains

Escitalopram has been studied across 19 research domains including 🌤️ Mood & Depression, 🧘 Stress & Anxiety, 😴 Sleep, 🧠 Cognitive, ⏳ Longevity & Aging. The primary research focus is 🌤️ Mood & Depression with 79% of studies addressing this area.

Loading evidence profile...

This evidence profile for Escitalopram is generated deterministically from 995 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.